WCM
DERM icon

Wealthcare Capital Management’s Journey Medical DERM Stock Holding History

Wealthcare Capital Management’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,000
Closed -$56.5K – 88
2024
Q3 		$56.5K Buy
+10,000
New +$51.5K 0.01% 82

Other funds holding DERM

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
GWM
Geneos Wealth Management Englewood, Colorado $4.31B AUM 18.36% 1-Year Est. Return
IWC
Integrated Wealth Concepts Waltham, Massachusetts $12.5B AUM 18.49% 1-Year Est. Return

Wealthcare Capital Management's DERM Position: Q4 2024 in Review

Wealthcare Capital Management sold out of Journey Medical (DERM) in Q4 2024, closing a stake of 10,000 shares — an estimated $56.5K sold.

Wealthcare Capital Management first reported a position in DERM in Q3 2024 and held it in 1 quarter. The position peaked at $56.5K in Q3 2024. 37 funds tracked by Wall St. Rank hold DERM as of Q4 2024.

  • Wealthcare Capital Management reported no remaining Journey Medical position as of Q4 2024 after selling out during the quarter.
  • Wealthcare Capital Management sold 10,000 Journey Medical shares in Q4 2024, an estimated $56.5K.
  • Wealthcare Capital Management first reported a position in Journey Medical in Q3 2024 and held it in 1 quarter.
  • Wealthcare Capital Management's Journey Medical position peaked at $56.5K in Q3 2024.
  • 37 funds tracked by Wall St. Rank held Journey Medical as of Q4 2024.

Based on Wealthcare Capital Management's 13F filing for Q4 2024, filed 15 Jan 2025.